Avacta Group (LON:AVCT) Stock Passes Above 200 Day Moving Average – Here’s Why

Avacta Group Plc (LON:AVCT) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 37.59 ($0.51) and traded as high as GBX 48.68 ($0.66). Avacta Group shares last traded at GBX 46.88 ($0.63), with a volume of 1,229,022 shares changing hands.

Avacta Group Stock Up 5.2%

The stock has a market cap of £183.88 million, a P/E ratio of -6.23 and a beta of 1.12. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 52.53. The business has a 50-day simple moving average of GBX 37.35 and a 200-day simple moving average of GBX 37.59.

Avacta Group (LON:AVCT) last announced its earnings results on Friday, June 6th. The biotechnology company reported GBX (8.54) (($0.12)) earnings per share (EPS) for the quarter. Avacta Group had a negative return on equity of 74.00% and a negative net margin of 114.45%. Analysts expect that Avacta Group Plc will post -9.9011833 EPS for the current year.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).